Sports Medicine Market is expected to grow from USD 5.38 billion in 2021 to USD 7.77 billion by 2028, at a CAGR of 5.4% during the forecast period 2022 to 2028. Sports medicine is the branch of medicine concerned with the physiological aspects of athletic performance especially treatment of injuries in sports and exercise. Sports medicine is also known as sports and exercise medicine (SEM). In general, sports medicine are used in prevention or immediate treatment of musculoskeletal injuries such as contusions, sprains, strains, meniscal injuries, bursitis and fractures & dislocations, which occur during the sports/exercise. Sports medicine market is expected to grow at significant rate owing to growing incidents of sports injuries. Sports medicicne market is characterised by diverse presence of multinational and regional market players. People who participate in sports have a high rate of ligament tears and fractures. In addition, sports injuries to the lower extremities account for a significant share of all injuries in the world. The demand for injury treatment and rehabilitation is predicted to rise across the country as more people participate in sports (both children and adults) and the frequency of sports injuries rises. Companies are adopting collaborations and alliances for increasing their market revenue share. For instance, in May 2017, Stryker and AlloSource are collaborated to distribute biologics for sports medicine procedures. Through this collaboration, stryker sports medicine sales force will distribute AlloSource biologics for various sports medicine procedures. Furthermore, companies are acquiring small and medium-sized market players to diversify the product portfolio and strengthen their market position. For instance, in February 2015, DePuy Synthes Companies (Subsidiary of Johnson & Johnson Servieces Inc.) acquired Olive Medical Corporation, provider of high definition visualisation systems for minimally invasive surgeries, this acquisition aguments DePuy Synthes Miteck Sports medicine line.Emerging countries such as India and China have a huge patient population and are likely to offer substantial growth prospects for sports medicine players, owing to rising disposable incomes (as a result of rapid economic expansion) and increased engagement in sports and physical activities.